In the last trading session, 88.37 million Hims & Hers Health Inc (NYSE:HIMS) shares changed hands as the company’s beta touched 1.40. With the company’s per share price at $49.28 changed hands at -$17.13 or -25.79% during last session, the market valuation stood at $10.77B. HIMS’s last price was a discount, traded about -48.09% off its 52-week high of $72.98. The share price had its 52-week low at $9.22, which suggests the last value was 81.29% up since then.
Analysts gave the Hims & Hers Health Inc (HIMS) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.38. If we narrow down to specifics, the data shows that 0 out of 13 analysts rate the stock as a Sell, with a further 1 assigning it an Overweight rating. Of the remaining, 5 recommended HIMS as a Hold, 7 felt it is a Buy and 0 rated the stock as Underweight. Hims & Hers Health Inc’s EPS for the current quarter is expected to be 0.22.
Hims & Hers Health Inc (NYSE:HIMS) trade information
Instantly HIMS was in red as seen at the end of in last trading. With action -16.73%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 103.80%, with the 5-day performance at -16.73% in the red. However, in the 30-day time frame, Hims & Hers Health Inc (NYSE:HIMS) is 65.81% up.
The consensus price target for the stock as assigned by Wall Street analysts is 25, meaning bulls need a downside of -97.12% from its current market value. According to analyst projections, HIMS’s forecast low is 20 with 38 as the target high. To hit the forecast high, the stock’s price needs a 22.89% surge from its current level, while the stock would need to tank 59.42% for it to hit the projected low.
Hims & Hers Health Inc (HIMS) estimates and forecasts
Year-over-year growth is forecast to reach 67.79% up from the last financial year.
Consensus estimates given by 12 financial analysts project the company’s revenue in the current quarter to hit an average of 470.5M. 9 analysts are of the opinion that Hims & Hers Health Inc’s revenue for the current quarter will be 494.56M. The company’s revenue for the corresponding quarters a year ago was 246.62M and 278.17M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 90.78%. The estimates for the next quarter sales put growth at 77.79%.
The 2025 estimates are for Hims & Hers Health Inc earnings to increase by 590.70%.
Hims & Hers Health Inc (NYSE:HIMS)’s Major holders
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 6.8278% or 14.57 million shares worth $294.25 million as of 2024-06-30.
Among Mutual Funds, the top two as of Nov 30, 2024 were iShares Core S&P Smallcap ETF and iShares Russell 2000 ETF. With 12.28 shares estimated at $605.4 million under it, the former controlled 5.85% of total outstanding shares. On the other hand, iShares Russell 2000 ETF held about 2.54% of the shares, roughly 5.33 shares worth around $262.79 million.
